Overall rank by patents
#10,880
of 50,000 tracked assignees
USPTO PatentsView assignee record - 28 granted patents across 12 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A23K (FODDER).
The verdict
According to USPTO PatentsView, Blue ranks #10,880 of 50,000 tracked US assignees by granted-patent volume, with 28 patents across 12 technology areas.
Blue Buffalo Enterpises, Inc. has been granted 28 US utility patents between 2020 and 2025, placing Blue Buffalo Enterpises, Inc. at #10,880 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 4.3 claims per patent with primary concentration in A23K (FODDER). As a US Corporation, Blue Buffalo Enterpises, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Blue sits between Biofire Diagnostics, Llc (28 patents, rank #10,876) and Canon Nanotechnologies, Inc. (28 patents, rank #10,884) - the closest US assignees by grant volume. The composite Innovation Score of 46.4/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Historical data spans 2020 through 2025, with 28 total grants over that period. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Blue Buffalo Enterpises, Inc.'s 4.3 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 12 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
BioFire Diagnostics, LLC
28 patents
Bioness Inc.
28 patents
Bitvore Corp.
28 patents
Blakely Ventures, LLC
28 patents
Bracco Diagnostics Inc.
28 patents
Brose Schliessysteme GmbH & Co. KG
28 patents
CANON ELECTRON TUBES & DEVICES CO., LTD.
28 patents
CANON NANOTECHNOLOGIES, INC.
28 patents
Blue Buffalo Enterpises, Inc.
28 patents
What this shows Blue holds 28 patents at rank #10,880, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #10,880 in granted patent volume.
Other assignees with the most granted patents in Blue's primary technology class.
Blue's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
46 Top 21% higher than 79% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 3.6% |
| 2021 | 5 | 17.9% |
| 2022 | 3 | 10.7% |
| 2023 | 8 | 28.6% |
| 2024 | 7 | 25.0% |
| 2025partial year | 4 | 14.3% |
Top 12 of 12 technology areas
Historical grant data only; it does not rate legal strength or current strategy.
Overall rank by patents
#10,880
of 50,000 tracked assignees
46.4 out of 100
How to use this portfolio
Blue's 28 grants land it in the top 21% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.